Luteolin: a blocker of SARS-CoV-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynamics

29Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

Natural products have served human life as medications for centuries. During the outbreak of COVID-19, a number of naturally derived compounds and extracts have been tested or used as potential remedies against COVID-19. Tetradenia riparia extract is one of the plant extracts that have been deployed and claimed to manage and control COVID-19 by some communities in Tanzania and other African countries. The active compounds isolated from T. riparia are known to possess various biological properties including antimalarial and antiviral. However, the underlying mechanism of the active compounds against SARS-CoV-2 remains unknown. Results in the present work have been interpreted from the view point of computational methods including molecular dynamics, free energy methods, and metadynamics to establish the related mechanism of action. Among the constituents of T. riparia studied, luteolin inhibited viral cell entry and was thermodynamically stable. The title compound exhibit residence time and unbinding kinetics of 68.86 ms and 0.014 /ms, respectively. The findings suggest that luteolin could be potent blocker of SARS-CoV-2 cell entry. The study shades lights towards identification of bioactive constituents from T. riparia against COVID-19, and thus bioassay can be carried out to further validate such observations.

References Powered by Scopus

Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers

16684Citations
N/AReaders
Get full text

Polymorphic transitions in single crystals: A new molecular dynamics method

15078Citations
N/AReaders
Get full text

LINCS: A Linear Constraint Solver for molecular simulations

14788Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2

17Citations
N/AReaders
Get full text

Effectivity of repurposed drugs against SARS-CoV-2 infections, A hope for COVID 19: inhibitor modelling studies by docking and molecular dynamics

9Citations
N/AReaders
Get full text

Successful Treatment of a Patient With Severe COVID-19 Using an Integrated Approach Addressing Mast Cells and Their Mediators

9Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Shadrack, D. M., Deogratias, G., Kiruri, L. W., Onoka, I., Vianney, J. M., Swai, H., & Nyandoro, S. S. (2021). Luteolin: a blocker of SARS-CoV-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynamics. Journal of Molecular Modeling, 27(8). https://doi.org/10.1007/s00894-021-04833-x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

41%

Researcher 9

41%

Lecturer / Post doc 3

14%

Professor / Associate Prof. 1

5%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 8

40%

Biochemistry, Genetics and Molecular Bi... 6

30%

Chemistry 4

20%

Medicine and Dentistry 2

10%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 7

Save time finding and organizing research with Mendeley

Sign up for free